Quibim, a Valencia-based health technology startup, has successfully raised $50 million in a Series A financing round aimed at advancing its AI-powered medical imaging capabilities. The funding was co-led by Asabys and Buenavista, with participation from Amadeus Capital. Quibim focuses on developing foundational AI models that enhance precision medicine through the use of imaging biomarkers, enabling early disease detection and improved treatment outcomes. CEO Ángel Alberich-Bayarri highlighted the company's commitment to generating actionable insights from various imaging modalities, including MRI, CT, and PET scans. This funding will support Quibim's vision of transforming medical processes and advancing the field of precision medicine.